Literature DB >> 17184907

Analysis of ligand-dependent recruitment of coactivator peptides to RXRbeta in a time-resolved fluorescence resonance energy transfer assay.

Deborah K Stafslien1, Kevin L Vedvik, Therese De Rosier, Mary Szatkowski Ozers.   

Abstract

Because RXR plays a significant role in nuclear receptor signaling as a common heterodimeric partner for TR, PPAR, RAR, VDR, LXR and others, the ability of RXRbeta ligand binding domain (LBD) to interact with coregulator peptides bearing LXXLL or other interaction motifs was investigated using time-resolved fluorescence resonance energy transfer (TR-FRET). The random phage display peptide D22 and peptides derived from PGC1alpha, SRC1-4, SRC2-3, PRIP/RAP250 and RIP140 yielded the highest TR-FRET signal with RXRbeta LBD in the presence of saturating 9-cis retinoic acid (9-cisRA). Several peptides including D22, PGC1alpha, SRC3-2, PRIP/RAP250 and SRC1-4 also formed a complex with RXRbeta LBD in the presence of all-trans retinoic acid (at-RA) and the fatty acids, phytanic acid (PA) and docosahexaenoic acid (DHA). Determination of the dose dependency (EC50) of these compounds to recruit D22 to RXRbeta LBD indicated that the rank order potency was 9-cisRA>PA>at-RA>DHA. The ligands 9-cisRA and at-RA yielded an overall higher fold-change in D22 recruitment to RXRbeta LBD suggesting that more RXRbeta LBD-D22 complex was formed in the presence of these ligands under the assay conditions tested. The statistical parameter Z' factor for 9-cisRA-induced recruitment of D22 to RXRbeta LBD was 0.6 after 2h incubation, indicating a robust methodology that could be applied to high throughput screening. These results demonstrate that RXRbeta occupied with the fatty acid ligands, DHA and PA, can recruit coactivator peptides in a ligand-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17184907     DOI: 10.1016/j.mce.2006.10.016

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  13 in total

1.  Differential interactions of antiretroviral agents with LXR, ER and GR nuclear receptors: potential contributing factors to adverse events.

Authors:  J Svärd; F Blanco; D Nevin; D Fayne; F Mulcahy; M Hennessy; J P Spiers
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

2.  Quantification of ligand-regulated nuclear receptor corepressor and coactivator binding, key interactions determining ligand potency and efficacy for the thyroid hormone receptor.

Authors:  M Jeyakumar; Paul Webb; John D Baxter; Thomas S Scanlan; John A Katzenellenbogen
Journal:  Biochemistry       Date:  2008-06-18       Impact factor: 3.162

3.  Polypharmacology of N6-(3-Iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA) and Related A3 Adenosine Receptor Ligands: Peroxisome Proliferator Activated Receptor (PPAR) γ Partial Agonist and PPARδ Antagonist Activity Suggests Their Antidiabetic Potential.

Authors:  Jinha Yu; Seyeon Ahn; Hee Jin Kim; Moonyoung Lee; Sungjin Ahn; Jungmin Kim; Sun Hee Jin; Eunyoung Lee; Gyudong Kim; Jae Hoon Cheong; Kenneth A Jacobson; Lak Shin Jeong; Minsoo Noh
Journal:  J Med Chem       Date:  2017-08-28       Impact factor: 7.446

Review 4.  Mechanisms of gene regulation by fatty acids.

Authors:  Anastasia Georgiadi; Sander Kersten
Journal:  Adv Nutr       Date:  2012-03-01       Impact factor: 8.701

5.  Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.

Authors:  Arjen Koppen; Rene Houtman; Dirk Pijnenburg; Ellen H Jeninga; Rob Ruijtenbeek; Eric Kalkhoven
Journal:  Mol Cell Proteomics       Date:  2009-07-10       Impact factor: 5.911

6.  A dual-acceptor time-resolved Föster resonance energy transfer assay for simultaneous determination of thyroid hormone regulation of corepressor and coactivator binding to the thyroid hormone receptor: Mimicking the cellular context of thyroid hormone action.

Authors:  M Jeyakumar; John A Katzenellenbogen
Journal:  Anal Biochem       Date:  2008-12-07       Impact factor: 3.365

Review 7.  Using TR-FRET to Investigate Protein-Protein Interactions: A Case Study of PXR-Coregulator Interaction.

Authors:  Wenwei Lin; Taosheng Chen
Journal:  Adv Protein Chem Struct Biol       Date:  2017-08-31       Impact factor: 3.507

8.  Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787.

Authors:  Prajakta S Palkar; Michael G Borland; Simone Naruhn; Christina H Ferry; Christina Lee; Ugir H Sk; Arun K Sharma; Shantu Amin; Iain A Murray; Cherie R Anderson; Gary H Perdew; Frank J Gonzalez; Rolf Müller; Jeffrey M Peters
Journal:  Mol Pharmacol       Date:  2010-06-01       Impact factor: 4.054

9.  The molecular basis of the interactions between synthetic retinoic acid analogues and the retinoic acid receptors.

Authors:  Hesham Haffez; David R Chisholm; Roy Valentine; Ehmke Pohl; Christopher Redfern; Andrew Whiting
Journal:  Medchemcomm       Date:  2017-01-20       Impact factor: 3.597

10.  Effect of synthetic dietary triglycerides: a novel research paradigm for nutrigenomics.

Authors:  Linda M Sanderson; Philip J de Groot; Guido J E J Hooiveld; Arjen Koppen; Eric Kalkhoven; Michael Müller; Sander Kersten
Journal:  PLoS One       Date:  2008-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.